AJP - GI Fuel your research with LabChart
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am J Physiol Gastrointest Liver Physiol 293: G335-G346, 2007. First published April 12, 2007; doi:10.1152/ajpgi.00425.2006
0193-1857/07 $8.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
293/1/G335    most recent
00425.2006v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via ISI Web of Science (2)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kirkland, J. G.
Right arrow Articles by Corvera, C. U.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kirkland, J. G.
Right arrow Articles by Corvera, C. U.

LIVER AND BILIARY TRACT

Agonists of protease-activated receptors 1 and 2 stimulate electrolyte secretion from mouse gallbladder

Jacob G. Kirkland,1,3 Graeme S. Cottrell,1,2 Nigel W. Bunnett,1,2 and Carlos U. Corvera1,3

Departments of 1Surgery and 2Physiology, University of California San Francisco, and 3Veterans Affairs Medical Center, San Francisco, California

Submitted 13 September 2006 ; accepted in final form 12 April 2007

Cholecystitis is one of the most common gastrointestinal diseases. Inflammation induces the activation of proteases that can signal to cells by cleaving protease-activated receptors (PARs) to induce hemostasis, inflammation, pain, and repair. However, the distribution of PARs in the gallbladder is unknown, and their effects on gallbladder function have not been fully investigated. We localized immunoreactive PAR1 and PAR2 to the epithelium, muscle, and serosa of mouse gallbladder. mRNA transcripts corresponding to PAR1 and PAR2, but not PAR4, were detected by RT-PCR and sequencing. Addition of thrombin and a PAR1-selective activating peptide (TFLLRN-NH2) to the serosal surface of mouse gallbladder mounted in an Ussing chamber stimulated an increase in short-circuit current in wild-type but not PAR1 knockout mice. Similarly, serosally applied trypsin and PAR2 activating peptide (SLIGRL-NH2) increased short-circuit current in wild-type but not PAR2 knockout mice. Proteases and activating peptides strongly inhibited electrogenic responses to subsequent stimulation with the same agonist, indicating homologous desensitization. Removal of HCO3 ions from the serosal buffer reduced responses to thrombin and trypsin by >80%. Agonists of PAR1 and PAR2 increase intracellular Ca2+ concentration in isolated and cultured gallbladder epithelial cells. The COX-2 inhibitor meloxicam and an inhibitor of CFTR prevented the stimulatory effect of PAR1 but not PAR2. Thus PAR1 and PAR2 are expressed in the epithelium of the mouse gallbladder, and serosally applied proteases cause a HCO3 secretion. The effects of PAR1 but not PAR2 depend on generation of prostaglandins and activation of CFTR. These mechanisms may markedly influence fluid and electrolyte secretion of the inflamed gallbladder when multiple proteases are generated.

bicarbonate transport; epithelial transport



Address for reprint requests and other correspondence: C. U. Corvera, Veterans Administrative Medical Center, Surgical Service (112), Bldg. 200, 4150 Clement St., San Francisco, California 94121 (e-mail: carlos.corvera{at}med.va.gov)







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online
Copyright © 2007 by the American Physiological Society.